Back
Neoadjuvant Therapy for Locally Advanced Renal Cell Carcinoma with Sorafenib in a Reference Center in Mexico
Axel Costilla-Montero, Benjamín Guadarrama-Benítez, Marco A. Aragón-Castro, Omar Morales-Ordaz, Rubén Gutiérrez-Rosales, Claudia Carrillo-Ponce, Marcela Janka-Zires, Luis Gabriel Vázquez-Lavista
Surg. Sci. Vol.2 No.6, August 16, 2011  DOI: 10.4236/ss.2011.26077
       (PDF  88K)     HTML     
Time to Progression of AFP (TPA) as a Predictor of Survival in Hepatocellular Carcinoma Treated with Sorafenib (SOR)
Maria Varela, Olegario Castaño-Fernández, Marcelo Garrido, Lorena Blanco-García, Pablo Martínez-Camblor, Alicia Mesa-Álvarez, Carmen Navascués, Valle Cadahía-Rodrigo, Rafael Menéndez de Llano, Ramon Pérez-Álvarez, Maria Luisa González-Diéguez, Manuel Rodríguez
J. Cancer Ther. Vol.5 No.14, December 03, 2014  DOI: 10.4236/jct.2014.514133
       (PDF  2842K)     HTML      XML
Metastatic sarcomatoid renal cell carcinoma to the mandible treated with Sorafenib
Kazuhiro Murakami, Kazuhiko Yamamoto, Kumiko Aoki, Ikuyo Fukumoto, Tsutomu Sugiura, Tadaaki Kirita
Open J. Stomatol. Vol.2 No.3, September 27, 2012  DOI: 10.4236/ojst.2012.23039
       (PDF  1657K)     HTML      XML
Can we achieve complete remission in locally advanced unresectable Hepatocellular Carcinoma (HCC) by using Sorafenib? Case report and review of literature from Qatar
Kakil Ibrahim Rasul
Mod. Chemother. Vol.1 No.1, July 23, 2012  DOI: 10.4236/mc.2012.11001
       (PDF  846K)     HTML     
Better Management of Adverse Events Favors Sorafenib Treatment of HCC Patients and Impact on Survival
Regiane S. S. M. Alencar, Luciana Kikuchi, Cláudia M. Tani, Aline L. Chagas, Cinira C. Camargo, Túlio E. F. Pfiffer, Paulo M. G. Hoff, Flair J. Carrilho
J. Cancer Ther. Vol.7 No.4, April 22, 2016  DOI: 10.4236/jct.2016.74029
       (PDF  636K)     HTML      XML
 
 
Top